Methods: Infants aged 6-23 months with upper respiratory tract complaints and reporting previous wheezing were followed-up retrospectively. Data were registered on a validated standardized form.
Introduction
episode of wheezing in infants are respiratory syncytial virus and rhinovirus and, less often, parainfluenza, metapneumovirus, coronavirus, influenza, bocavirus and adenovirus have also been identified in this context. 5 To date, the characteristics of recurrent wheezing among infants in the city of Salvador, BA, Brazil, are unknown.
The objectives of this study were to estimate the frequency of previous history of wheezing episodes in infants (6 to 23 months old) and describe their clinical characteristics and the forms of treatment used during these episodes. The following definitions were adopted: occasional wheezing (up to two episodes), recurrent wheezing (three or more episodes), severe recurrent wheezing (more than six episodes) 7 and severe wheezing (emergency visit or hospital admission, or frequent waking at night, or difficulties breathing during a wheezing episode). 8 The database was input to Epi-Info 6.04 and analyses were conducted using SPSS 9.0. 
Patients and methods

Between
Results
Of a total of 451 children assessed, 164 (36.4%; 95%CI = 31.9-41.0) had a previous history of wheezing and 148
(32.8%; 95%CI = 28.5-37.4) had a history of wheezing in the first year of life.
The mean age of children with previous wheezing was 15±5 months (range = 6 to 23.9 months), and 62 (37.8%) of them were less than 1 year old. There were 98 boys (59.8%). The mean age of the children at the first episode of wheezing was 5.3±3.9 months (median = 5 months) and in 58.5% the first episode occurred before 6 months and in the first year of life in 90.2% (Table 1) . Age at first episode of wheezing was 4.4±2.9 months for children who had first symptoms during the first year of life and was 3.2±2.7 months for those who also had recurrent wheezing.
Recurrent wheezing affected 52.7% of infants who had their first symptoms during their first year of life, and was severe in 14.2% of these cases. With respect to the study group as a whole, the most often employed treatments during wheezing episodes were bronchodilators (89.6%) and oral corticoids (46.3%) ( Table 2) . Table 2 shows the frequencies of different characteristics of wheezing episodes for the subset of infants who wheezed at least once during the first year of life and for the subset with recurrent wheezing during the first year of life. Severe wheezing was detected in 141 (86%) infants and mean age for patients with severe wheezing was 5±4 and for those without severe wheezing mean age was 7±4 (p = 0.04; difference between means = 2; 95%CI = 0.4-3.5).
Discussion
Of note is the early age at which the children studied presented their first episodes of wheezing, particularly those with recurrent cases (mean = 3.2 months), which is a younger mean age than observed by studies undertaken in cities in
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the South and Southeast of Brazil, despite these having been undertaken at public services destined to underprivileged populations. [9] [10] [11] A Dutch study documented a lower mean age of onset of wheezing (1.7±3.0 months) and observed a strong association between exposure to humidity at home and wheezing episodes. 12 In contrast, a study of childhood asthma conducted in the city of Salvador found there was no association between atopic disease and the majority of cases of asthma in the population, 3 suggesting that there was a stronger relationship between wheezing episodes and UARI and with lower airway respiratory diseases. 13 We found that 32.8% of the entire sample had a first episode of wheezing during the first year of life, which is a similar result to what was observed by the EISL, i.e., the prevalence of wheezing in developing countries is higher than in developed ones. 8, 12, 13 It is possible that local ecological and environmental factors may be responsible for these differences.
The prevalence of recurrent wheezing observed here (52.7%) was lower than has been reported by other studies conducted in the Southeast and South regions of Brazil. 9, 11 The same was true of the prevalence of severe recurrent wheezing. 9 The explanation for these differences is highly complex and involves multiple factors. One suggestion is that genetic and environmental interactions are distinct in every location and are capable of modulating airway responses from very early in life up to adulthood. 8 In this study, there was an elevated rate of concomitance between wheezing episodes and UARI (82.2%), in line with other studies that have suggested that 85% of wheezing episodes in infants have viral etiology. 4 Treatment of acute wheezing is with inhaled beta-2 agonist bronchodilators and oral corticosteroids for a limited period of time. 15 Therefore, the high frequency of administration of these medications in our sample of infants does not surprise us (89.6% were given bronchodilators and 46.3% oral corticosteroids). 8, 9 Beta-2 agonists offer rapid relief from symptoms, particularly bronchial obstruction. 16 The effect expected from the corticosteroids, via their potent anti-inflammatory properties, is repair of sequelae of the viral infection. However, several different studies using high and low doses of inhaled or systemic corticosteroids have reported conflicting results, since the majority were unable to demonstrate significant reductions in symptoms, length of hospital stay or need for mechanical ventilation. 17 In contrast, a very small proportion of patients were given leukotriene receptor antagonists to manage their wheezing, as has been reported in other studies. 8 The fact that this group of drugs is not dispensed by primary care providers, allied to their high cost, may explain this fact.
The earlier the first episode occurred, the more frequently severe wheezing was reported, although physiciandiagnosed asthma was rare (Table 2) Nevertheless, the sample recruitment team were trained intensively and its members were medical students, which, in conjunction with the adequate level of understanding and well-preserved memory on the part of the mothers interviewed (which has been demonstrated previously), 6, 9 indicates that the results should be trustworthy.
We conclude that wheezing is a sign with early onset and elevated prevalence in the city of Salvador, although prevalence is lower than has been reported by studies undertaken in other Brazilian cities. A significant percentage of these patients are treated with systemic corticosteroids, possibly justified by the severity of the episodes.
